Hypereosinophilia (eosinophils > 0.5 G/L)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Sign of organ involvement: emergency
- Hospital admission without waiting for the aetiological work-up (cardiac, respiratory, central neurological involvement or thrombosis).
- Before any corticosteroid therapy, take a strongyloidiasis serology.
Eosinophils 0.5 to 1.5 G/L without severity signs
Laboratory tests
- FBC with differential count (repeat)
- HIV serology (if risk factor)if neededRisk factor for HIV infection, rarer cause of eosinophilia between 0.5 and 1.5 G/L [2].
- Stool parasitology (if persistent without obvious cause, digestive symptoms or passage of proglottids)if neededPersistence without obvious cause, digestive symptoms or passage of proglottids: Taenia and Diphyllobothrium are diagnosed by stool parasitology (EPS) [2].
- Blood filmif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- CRPif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- Serum creatinineif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- ASTif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- ALTif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- GGTif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- Alkaline phosphataseif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- Bilirubinif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- Serum calciumif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
- LDHif needednon-French guidelineThe British guideline (BSH, 2017, grade 1C) asks for this baseline work-up, with vitamin B12, for any eosinophilia [3]; the Scottish NHS Lothian guide limits it to FBC, blood film, CRP, renal and liver function, LDH and 3 stool parasitology tests (EPS) [6]. The PNDS does not provide for it between 0.5 and 1.5 G/L and accepts adding nothing when there is an obvious atopic context [2].
Eosinophils > 1.5 G/L without severity signs
Laboratory tests
- FBC with blood film (repeat)
- Serum electrolytes
- Serum creatinine
- AST
- ALT
- GGT
- Alkaline phosphatase
- Bilirubin
- LDH
- Creatine kinase (CK)
- Serum calcium
- Serum phosphate
- Troponin, NT-proBNP
- Serum protein electrophoresis
- Serum tryptase
- Vitamin B12
- Total IgE
- CRP
- HIV serology
- Toxocariasis serology
- Stool parasitology
- Search for Strongyloides larvae in stool (Baermann) (if strongyloidiasis suspected)if neededSuspected strongyloidiasis, to be considered first after a stay in the tropics, even long ago [2].
- Strongyloidiasis serology (stay in a tropical area, or before corticosteroid therapy)if neededStay in the tropics, even long ago [2]; before any corticosteroid therapy, to exclude strongyloidiasis (risk of disseminated strongyloidiasis) [1,2].
- Fascioliasis serology (consumption of watercress or raw vegetables potentially contaminated)if neededSuggestive exposure: eating watercress or raw vegetables [2].
- Trichinellosis serology (myalgia, game or undercooked pork or horse meat)if neededSuggestive exposure: undercooked game, pork or horse meat; myalgia [2].
- ANCA (asthma, signs of vasculitis)if neededAsthma with hypereosinophilia: consider eosinophilic granulomatosis with polyangiitis (ANCA in 30 to 40%) [2].
- Antinuclear antibodies (ANA)if needednon-French guidelineThe British guideline (BSH, 2017) asks for them when a connective tissue disease is suspected [3]. The PNDS cites anti-CCP in inflammatory joint involvement, without including them in the minimal work-up [2].
- Anti-CCP antibodiesif needednon-French guidelineThe British guideline (BSH, 2017) asks for them when a connective tissue disease is suspected [3]. The PNDS cites anti-CCP in inflammatory joint involvement, without including them in the minimal work-up [2].
- IgA anti-tissue transglutaminase antibodies (tTG-IgA) (if diarrhoea or digestive signs)if needednon-French guidelineThe British guideline (BSH, 2017) includes coeliac disease serology when a digestive cause is suspected [3]. The PNDS reminds clinicians not to overlook this disease when there are digestive signs, without including it in the minimal work-up [2].
Imaging
- CT of chest, abdomen and pelvis; ECG and echocardiography if hypereosinophilia persists without cause.
Traveller or migrant (stay in a tropical area, even long ago)
Laboratory tests
- FBC with blood film
- Bilharziasis (schistosomiasis) serology
- Strongyloidiasis serology (strongyloidosis)
- Toxocariasis serology (if eosinophils > 1.5 G/L)if neededEosinophils > 1.5 G/L: complete with the work-up in the previous tab, which includes toxocariasis serology [2].
- HIV serology (if not done)if neededRoutine in hypereosinophilia > 1.5 G/L [2]; unnecessary if already done.
- HTLV-1 serology (origin or stay: Japan, Caribbean, sub-Saharan Africa)if neededOrigin from or stay in Japan, the Caribbean or sub-Saharan Africa [2].
- Filariasis serology and search for daytime microfilaraemia (origin in forested Central Africa, before any ivermectin)if neededPerson from forested Central Africa, before any ivermectin: if positive, no immediate treatment and infectious diseases advice (risk of severe effects in loiasis) [8].
Stool and urine
- Stool parasitology: 3 samples a few days apart
- Search for Strongyloides larvae in stool (Baermann)if neededSuspected strongyloidiasis, to be considered first after a stay in the tropics, even long ago [2].
- Urine parasitology (origin or stay in a schistosomiasis-endemic area): complete morning void or 24-hour urineif neededOrigin from or stay in a schistosomiasis-endemic area: test recommended in a migrant with eosinophilia [8].
Sources (17)
- Chappuis S, Ribi C, Greub G, Spertini F. Éosinophilie sanguine : quel bilan, quel cheminement diagnostique ? Rev Med Suisse. 2013;9(382):819-825.
- Centre de référence des syndromes hyperéosinophiliques (CEREO). Protocole national de diagnostic et de soins (PNDS) : hyperéosinophilies et syndromes hyperéosinophiliques. Haute Autorité de santé, juin 2022.
- Butt NM, Lambert J, Ali S, et al.; British Committee for Standards in Haematology. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176(4):553-572.
- Klion AD. Approach to the patient with suspected hypereosinophilic syndrome. Hematology Am Soc Hematol Educ Program. 2022;2022(1):47-54.
- Manchester University NHS Foundation Trust. Haematology GP Pathway Guides, version 4, mars 2026 : Eosinophilia.
- NHS Lothian. RefHelp : Eosinophilia (haematology referral guideline), version du 27 juillet 2023.
- Metzgeroth G, Reiter A, Goede J, Sperr WR, Valent P. Eosinophilie: Primäre klonale Eosinophile und Differentialdiagnosen. Leitlinie Onkopedia (DGHO), Stand Oktober 2023.
- Société de pathologie infectieuse de langue française (SPILF), Société française de pédiatrie (SFP), Société française de lutte contre le sida (SFLS). Bilan de santé à réaliser chez toute personne migrante primo-arrivante (adulte et enfant). Recommandation, juin 2024.
- Checkley AM, Chiodini PL, Dockrell DH, Bates I, et al.; British Infection Society. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect. 2010;60(1):1-20.
- Centre de référence des syndromes hyperéosinophiliques (CEREO). PNDS : hyperéosinophilies et syndromes hyperéosinophiliques. Version du 21 juin 2022 (paragraphe sur l'enquête médicamenteuse, encadré 3).
- Centre de référence des syndromes hyperéosinophiliques (CEREO). PNDS : hyperéosinophilies et syndromes hyperéosinophiliques. Version du 21 juin 2022 (paragraphe sur l'enquête médicamenteuse, encadré 3).
- Centre de référence des syndromes hyperéosinophiliques (CEREO). PNDS : hyperéosinophilies et syndromes hyperéosinophiliques. Version du 21 juin 2022 (paragraphe sur l'enquête médicamenteuse, encadré 3).
- Centre de référence des syndromes hyperéosinophiliques (CEREO). PNDS : hyperéosinophilies et syndromes hyperéosinophiliques. Version du 21 juin 2022 (paragraphe sur l'enquête médicamenteuse, encadré 3).
- Centre de référence des syndromes hyperéosinophiliques (CEREO). PNDS : hyperéosinophilies et syndromes hyperéosinophiliques. Version du 21 juin 2022 (paragraphe sur l'enquête médicamenteuse, encadré 3).
- Centre de référence des syndromes hyperéosinophiliques (CEREO). PNDS : hyperéosinophilies et syndromes hyperéosinophiliques. Version du 21 juin 2022 (paragraphe sur l'enquête médicamenteuse, encadré 3).
- Centre de référence des syndromes hyperéosinophiliques (CEREO). PNDS : hyperéosinophilies et syndromes hyperéosinophiliques. Version du 21 juin 2022 (paragraphe sur l'enquête médicamenteuse, encadré 3).
- Centre de référence des syndromes hyperéosinophiliques (CEREO). PNDS : hyperéosinophilies et syndromes hyperéosinophiliques. Version du 21 juin 2022 (paragraphe sur l'enquête médicamenteuse, encadré 3).